Clinical Trial, Open, Phase III, Multicenter, Randomized to Evaluate the Efficacy and Safety of the Use of Ozone Released by Philozon Medplus Device Versus Conventional Therapy in Treating Patients With Diabetic Foot.
This is a open, phase III, multicenter, prospective, comparative, controlled, randomized clinical trial to evaluate the efficacy and safety of the use of ozone released by Philozon Medplus device versus conventional therapy in treating patients with diabetic foot.
100 Clinical Results associated with Philozon Geradores de Ozonio LTDA
0 Patents (Medical) associated with Philozon Geradores de Ozonio LTDA
100 Deals associated with Philozon Geradores de Ozonio LTDA
100 Translational Medicine associated with Philozon Geradores de Ozonio LTDA